{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:28:52Z","timestamp":1761596932094},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1093\/ndt\/gfi219","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T03:28:31Z","timestamp":1129692511000},"page":"389-396","source":"Crossref","is-referenced-by-count":10,"title":["Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency"],"prefix":"10.1093","volume":"21","author":[{"given":"Peggy W. G.","family":"du Buf-Vereijken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack F. M.","family":"Wetzels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,10,18]]},"reference":[{"key":"key\n\t\t\t\t20171012195719_BIB1","doi-asserted-by":"crossref","unstructured":"Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976\u20131979 and 1995\u20131997. Am J Kidney Dis1997; 30: 621\u2013631","DOI":"10.1016\/S0272-6386(97)90485-6"},{"key":"key\n\t\t\t\t20171012195719_BIB2","doi-asserted-by":"crossref","unstructured":"Donadio JV Jr, Torres VE, Velosa JA et al. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int1988; 33: 708\u2013715","DOI":"10.1038\/ki.1988.56"},{"key":"key\n\t\t\t\t20171012195719_BIB3","doi-asserted-by":"crossref","unstructured":"Schieppati A, Mosconi L, Perna A et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med1993; 329: 85\u201389","DOI":"10.1056\/NEJM199307083290203"},{"key":"key\n\t\t\t\t20171012195719_BIB4","doi-asserted-by":"crossref","unstructured":"Ponticelli C, Zucchelli P, Passerini P et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int1995; 48: 1600\u20131604","DOI":"10.1038\/ki.1995.453"},{"key":"key\n\t\t\t\t20171012195719_BIB5","unstructured":"Reichert LJ, Koene RA, Wetzels JF. Urinary IgG excretion as a prognostic factor in idiopathic membranous nephropathy. Clin Nephrol1997; 48: 79\u201384"},{"key":"key\n\t\t\t\t20171012195719_BIB6","doi-asserted-by":"crossref","unstructured":"Reichert LJ, Koene RA, Wetzels JF. Urinary excretion of beta 2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy. J Am Soc Nephrol1995; 6: 1666\u20131669","DOI":"10.1681\/ASN.V661666"},{"key":"key\n\t\t\t\t20171012195719_BIB7","doi-asserted-by":"crossref","unstructured":"Branten AJ, du Buf-Vereijken PW, Klasen IS et al. Urinary excretion of \u03b22-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. J Am Soc Nephrol2005; 16: 169\u2013174","DOI":"10.1681\/ASN.2004040287"},{"key":"key\n\t\t\t\t20171012195719_BIB8","doi-asserted-by":"crossref","unstructured":"Bazzi C, Petrini C, Rizza V et al. Urinary excretion of IgG and alpha-1-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. Am J Kidney Dis2001; 38: 240\u2013248","DOI":"10.1053\/ajkd.2001.26080"},{"key":"key\n\t\t\t\t20171012195719_BIB9","doi-asserted-by":"crossref","unstructured":"Myers BD, Guasch A. Selectivity of the glomerular filtration barrier in healthy and nephrotic humans. Am J Nephrol1993; 13: 311\u2013317","DOI":"10.1159\/000168645"},{"key":"key\n\t\t\t\t20171012195719_BIB10","doi-asserted-by":"crossref","unstructured":"Magil AB. Tubulointerstitial lesions in human membranous glomerulonephritis: relationship to proteinuria. Am J Kidney Dis1995; 25: 375\u2013379","DOI":"10.1016\/0272-6386(95)90097-7"},{"key":"key\n\t\t\t\t20171012195719_BIB11","doi-asserted-by":"crossref","unstructured":"D\u2019Amico G, Ferrario F, Rastaldi MP. Tubulointerstitial damage in glomerular-diseases\u2014its role in the progression of renal damage. Am J Kidney Dis1995; 26: 124\u2013132","DOI":"10.1016\/0272-6386(95)90165-5"},{"key":"key\n\t\t\t\t20171012195719_BIB12","doi-asserted-by":"crossref","unstructured":"D\u2019Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int2003; 63: 809\u2013825","DOI":"10.1046\/j.1523-1755.2003.00840.x"},{"key":"key\n\t\t\t\t20171012195719_BIB13","unstructured":"Branten AJ, Wetzels JF. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Clin Nephrol2001; 56: 1\u20139"},{"key":"key\n\t\t\t\t20171012195719_BIB14","doi-asserted-by":"crossref","unstructured":"du Buf-Vereijken PW, Branten AJ, Wetzels JF. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate. Nephrol Dial Transplant2004; 19: 1142\u20131148","DOI":"10.1093\/ndt\/gfh036"},{"key":"key\n\t\t\t\t20171012195719_BIB15","unstructured":"Christensen CK, Mogensen CE, Hanberg SF. Renal function and cimetidine. Urinary albumin and beta 2-microglobulin excretion and creatine clearance during cimetidine treatment. Scand J Gastroenterol1981; 16: 129\u2013134"},{"key":"key\n\t\t\t\t20171012195719_BIB16","doi-asserted-by":"crossref","unstructured":"Jacobs EM, Vervoort G, Branten AJ et al. Atrial natriuretic peptide increases albuminuria in type I diabetic patients: evidence for blockade of tubular protein reabsorption. Eur J Clin Invest1999; 29: 109\u2013115","DOI":"10.1046\/j.1365-2362.1999.00422.x"},{"key":"key\n\t\t\t\t20171012195719_BIB17","doi-asserted-by":"crossref","unstructured":"Branten AJ, Wetzels JF. Influence of albumin infusion on the urinary excretion of beta2-microglobulin in patients with proteinuria. Nephron1999; 81: 329\u2013333","DOI":"10.1159\/000045301"},{"key":"key\n\t\t\t\t20171012195719_BIB18","doi-asserted-by":"crossref","unstructured":"Thomas DM, Hillis AN, Coles GA, Davies M, Williams JD. Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics. Am J Kidney Dis1991; 18: 38\u201343","DOI":"10.1016\/S0272-6386(12)80288-5"},{"key":"key\n\t\t\t\t20171012195719_BIB19","doi-asserted-by":"crossref","unstructured":"Campbell R, Sangalli F, Perticucci E et al. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int2003; 63: 1094\u20131103","DOI":"10.1046\/j.1523-1755.2003.00832.x"},{"key":"key\n\t\t\t\t20171012195719_BIB20","doi-asserted-by":"crossref","unstructured":"Lee TM, Su SF, Tsai CH. Effect of pravastatin on proteinuria in patients with well-controlled hypertension. Hypertension2002; 40: 67\u201373","DOI":"10.1161\/01.HYP.0000022805.11288.7F"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/2\/389\/5235217\/gfi219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T17:33:25Z","timestamp":1626629605000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/2\/389\/1850754\/Treatmentrelated-changes-in-urinary-excretion-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,18]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,10,18]]},"published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfi219","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,2]]},"published":{"date-parts":[[2005,10,18]]}}}